USP2 inhibition destabilizes CD47 and reshapes tumor microenvironment to enhance  cancer immunotherapy
USP2 inhibition by ML364 treatment significantlly suppressed tumor growth. We aim to investigate the impact of ML364 treatment on the immune microenvironment of tumor-bearing mice by single-cell sequencing.